Nyxoah SA (5YI)
FSX
Closed
Oct 9, 2026
Day's Range
1.0752 wk Range
0.9120Overview - 5YI - Nyxoah SA
Key Statistics
Valuation
Enterprise Value
67.47M
P/E (Trailing)
‪-0.44‬
P/E (Forward)
‪-0.73‬
PEG Ratio
‪-0.09‬
Price / Sales (TTM)
‪4.94‬
Price / Book
‪1.26‬
EV / EBITDA
‪-0.81‬
Profitability
Gross Margin
‪59.72%‬
Profit Margin
‪63.13%‬
Operating Margin
‪-268.24%‬
Return on Assets
‪-36.86%‬
Return on Equity
‪-122.68%‬
Ownership
Shares Outstanding
100.07M
Float
50.88M
Held by Insiders
‪33.19%‬
Held by Institutions
‪29.90%‬
Price stats
Beta
‪0.96‬
50-Day Avg
‪1.22‬
200-Day Avg
‪2.40‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 5YI - Nyxoah SA
Peers - 5YI - Nyxoah SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - 5YI - Nyxoah SA
About
Nyxoah SA is a medical technology company focused on developing and commercializing solutions for obstructive sleep apnea, a common sleep-disordered breathing condition. Nyxoah’s lead product is the Genio system, a patient-centered hypoglossal neurostimulation therapy designed to help treat moderate to severe…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
